On Monday, Hawkins received an upgrade to its Relative Strength (RS) Rating, from 68 to 78.
IBD's unique rating identifies price action with a 1 (worst) to 99 (best) score. The grade shows how a stock's price behavior over the trailing 52 weeks compares to all the other stocks in our database.
History reveals that the top-performing stocks tend to have an RS Rating of over 80 as they launch their largest climbs. See if Hawkins can continue to show renewed price strength and clear that threshold.
When To Sell Stocks To Lock In Profits And Minimize Losses
Hawkins is not currently offering a proper buying opportunity. See if the stock goes on to build a sound pattern that could launch a new move.
Earnings-per-share growth decreased last quarter from 5% to 1%, but revenue rose from 4% to 8%.
Hawkins holds the No. 1 rank among its peers in the Chemicals-Basic industry group. DuPont de Nemours and Westlake Chem Partners are also among the group's highest-rated stocks.
This article was created automatically with Stats Perform's Wordsmith software using data and article templates supplied by Investor's Business Daily. An IBD journalist may have edited the article.
RELATED:
IBD Stock Rating Upgrades: Rising Relative Strength
Why Should You Use IBD's Relative Strength Rating?
How Relative Strength Line Can Help You Judge A Stock
Ready To Grow Your Investing Skills? Join An IBD Meetup Group!
